Skip to main content

IPI Legacy Liquidation Co

IMPLDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001445499

IPI Legacy Liquidation Co was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Apr 9, 2024; 32 institutions reported holding it in 13F filings for Q3 2023, worth $7.35M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding IPI Legacy Liquidation Co changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of IMPL: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3935−4
Shares15.2M17.9M+2.74M (+18.1%)
Value$73.9M$56.3M−$17.5M (−23.7%)

New holders (6)

Institutions that held IPI Legacy Liquidation Co at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to IMPL in Q4 2022
InstitutionSharesValue% of portfolio
NVP Associates, LLC3,077,198$11.5M11.26%
J. Goldman & Co LP200,219$750.8K0.05%
Raymond James & Associates14,500$54.4K0.00%
Jane Street Group, LLC13,147$49.3K0.00%
McDonald Partners LLC11,700$43.9K0.01%
NewSquare Capital LLC20$750.00%

Sold out (10)

Institutions that held IPI Legacy Liquidation Co at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of IMPL in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Opaleye Management Inc.255,250$1.24M
Millennium Management LLC31,842$155.0K
Ergoteles LLC24,447$119.0K
Goldman Sachs Group Inc11,220$55.0K
Tower Research Capital LLC (TRC)10,245$50.0K
BNP Paribas Arbitrage, SA1,369$6.67K
China Universal Asset Management Co., Ltd.223$1.00K
FMR LLC95$0
Royal Bank of Canada75$0
Ellevest, Inc.8$0